Impact of sacubitril/valsartan on lipid parameters in patients with heart failure with reduced ejection fraction

11 May 2026 (09:47 - 11:04)

Organised by:

Abstract

Slides

Sign in for access options

About the speaker

Doctor Ipek Aydin

Istanbul University-Cerrahpasa Institute of Cardiology, Istanbul (Turkiye)

5 More presentations in this session

Presentation thumbnail

Efficacy and safety of intravenous sodium ferric gluconate complex in iron-deficient patients hospitalized for heart failure: a meta-analysis

Miss B. Tran (Debrecen, HU)

Abstract Slides

Presentation thumbnail

The role of Ivabradine in hospitalized acute decompensated heart failure patients: a single center retrospective study

Associate Professor S. AHMED (Ras Al Khaimah, AE)

Abstract Slides

Presentation thumbnail

Frailty is associated with suboptimal guideline-directed medical therapy in heart failure hospital admissions

Mr A. Maggi (Brescia, IT)

Abstract Slides

Presentation thumbnail

The real-world use of benefit-unproven ARBs in HFrEF: clinical outcomes and prescription patterns

Assistant Professor J. Park (Busan, KR)

Abstract Slides

Presentation thumbnail

Exogenous tetrahydrobiopterin supplementation ameliorates heart failure with preserved ejection fraction by attenuating metabolic dysregulation and cardiac oxidative stress

Assistant Professor Y. Cai (Hung Hom, HK)

Abstract Slides

Access the full session

Session thumbnail

ePosters in chronic heart failure - pharmacotherapy (1)

The Event

Event poster

Heart Failure 2026

11 May 2026 09:47 CET

You may be interested in

Congress Session

Guideline-directed medical therapy implementation in special clinical scenarios

Congress Presentation

Audience Q&A

Congress Session

Navigating through heart failure device therapies

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources